Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin C Thomas

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Kidney International|May 11, 2005
Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetesMerlin C Thomas, George Jerums, Con Tsalamandris, et al.
The Medical Journal of Australia|June 12, 2002
Appetising solutions: an edible vaccine for measlesDiane E Webster, Merlin C Thomas, Richard A Strugnell, et al.
Endocrine Connections|May 9, 2023
SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative reviewMerlin C Thomas, Brendon L Neuen, Stephen M Twigg, et al.
Diabetes Care|June 6, 2025
Kidney Disease: The Forgotten Legacy of Type 1 DiabetesMerlin C Thomas, Sophia Zoungas, Nordin M J Hanssen, et al.
Diabetes|March 30, 2004
Improved islet morphology after blockade of the renin- angiotensin system in the ZDF ratChristos Tikellis, Peter J Wookey, Riccardo Candido, et al.
Kidney International. Supplement|October 16, 2004
The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetesJosephine M Forbes, Merlin C Thomas, Suzanne R Thorpe, et al.
The Medical Journal of Australia|August 9, 2006
The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)Merlin C Thomas, Andrew J Weekes, Olivia J Broadley, et al.
Physiological Reviews|February 7, 2025
Molecular dissection of the role of ACE2 in glucose homeostasisKavaljit H Chhabra, Robin Shoemaker, Chandana B Herath, et al.
Diabetes|April 28, 2011
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathyMichal Herman-Edelstein, Merlin C Thomas, Vicki Thallas-Bonke, et al.
Kidney International|August 26, 2004
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetesMerlin C Thomas, Con Tsalamandris, Richard MacIsaac, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Kidney International|May 11, 2005
Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetesMerlin C Thomas, George Jerums, Con Tsalamandris, et al.
The Medical Journal of Australia|June 12, 2002
Appetising solutions: an edible vaccine for measlesDiane E Webster, Merlin C Thomas, Richard A Strugnell, et al.
Endocrine Connections|May 9, 2023
SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative reviewMerlin C Thomas, Brendon L Neuen, Stephen M Twigg, et al.
Diabetes Care|June 6, 2025
Kidney Disease: The Forgotten Legacy of Type 1 DiabetesMerlin C Thomas, Sophia Zoungas, Nordin M J Hanssen, et al.
Diabetes|March 30, 2004
Improved islet morphology after blockade of the renin- angiotensin system in the ZDF ratChristos Tikellis, Peter J Wookey, Riccardo Candido, et al.
Kidney International. Supplement|October 16, 2004
The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetesJosephine M Forbes, Merlin C Thomas, Suzanne R Thorpe, et al.
The Medical Journal of Australia|August 9, 2006
The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)Merlin C Thomas, Andrew J Weekes, Olivia J Broadley, et al.
Physiological Reviews|February 7, 2025
Molecular dissection of the role of ACE2 in glucose homeostasisKavaljit H Chhabra, Robin Shoemaker, Chandana B Herath, et al.
Diabetes|April 28, 2011
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathyMichal Herman-Edelstein, Merlin C Thomas, Vicki Thallas-Bonke, et al.
Kidney International|August 26, 2004
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetesMerlin C Thomas, Con Tsalamandris, Richard MacIsaac, et al.
Pageof 18